Genomic and functional comparison of mesenchymal stromal cells prepared using two isolation methods

Cytotherapy

Volumn 17, Issue 3, 2015, Pages 262-270

  Otsuru, Satoru ^a,b   Hofmann, Ted J ^a   Raman, Pichai ^c   Olson, Timothy S ^a   Guess, Adam J ^b   Dominici, Massimo ^d   Horwitz, Edwin M ^a,b,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Bone marrow MSC; Cryopreservation; Functional assay; Gene expression profile

Indexed keywords

ADULT; ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; DENSITY GRADIENT CENTRIFUGATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LABORATORY DEVICE; MALE; MESENCHYMAL STROMA CELL; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEPARATION FILTER DEVICE; ANIMAL; BIOLOGICAL THERAPY; BONE MARROW; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL SEPARATION; COMPARATIVE STUDY; CYTOLOGY; DEVICES; GENE EXPRESSION PROFILING; GENOMICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; PROCEDURES; XENOGRAFT; YOUNG ADULT;

ADULT; ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CHONDROCYTES; CRYOPRESERVATION; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MIDDLE AGED; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 84924971374     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.10.013     Document Type: Article

References (42)

1. Dominici M., Paolucci P., Conte P., Horwitz E.M. Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation 2009, 87:S36-42.
2. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
3. Meirelles Lda S., Nardi N.B. Methodology, biology and clinical applications of mesenchymal stem cells. Front Biosci (Landmark Ed) 2009, 14:4281-4298.
4. Schipani E, Kronenberg HM. Adult mesenchymal stem cells. StemBook. Cambridge MA: 2008 Ernestina Schipani and Henry M. Kronenberg.;2008.
5. von Bonin M., Stolzel F., Goedecke A., Richter K., Wuschek N., Holig K., et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 2009, 43:245-251.
6. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002, 99:8932-8937.
7. Otsuru S., Gordon P.L., Shimono K., Jethva R., Marino R., Phillips C.L., et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 2012, 120:1933-1941.
8. Otsuru S., Hofmann T.J., Olson T.S., Dominici M., Horwitz E.M. Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy 2013, 15:146-153.
9. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
10. Alves H., van Ginkel J., Groen N., Hulsman M., Mentink A., Reinders M., et al. Amesenchymal stromal cell gene signature for donor age. PLoS One 2012, 7:e42908.
11. Muschler G.F., Boehm C., Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. JBone Joint Surg Am 1997, 79:1699-1709.
12. Phinney D.G. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. JCell Biochem 2012, 113:2806-2812.
13. Phinney D.G., Kopen G., Isaacson R.L., Prockop D.J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. JCell Biochem 1999, 72:570-585.
14. Phinney D.G., Kopen G., Righter W., Webster S., Tremain N., Prockop D.J. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. JCell Biochem 1999, 75:424-436.
15. Samuelsson H., Ringden O., Lonnies H., Le Blanc K. Optimizing invitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy 2009, 11:129-136.
16. Siddappa R., Licht R., van Blitterswijk C., de Boer J. Donor variation and loss of multipotency during invitro expansion of human mesenchymal stem cells for bone tissue engineering. JOrthop Res 2007, 25:1029-1041.
17. Wagner W., Ho A.D. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 2007, 3:239-248.
18. Zhou S., Greenberger J.S., Epperly M.W., Goff J.P., Adler C., Leboff M.S., et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008, 7:335-343.
19. Zhukareva V., Obrocka M., Houle J.D., Fischer I., Neuhuber B. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine 2010, 50:317-321.
20. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., et al. Arandomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. JAm Coll Cardiol 2009, 54:2277-2286.
21. Kebriaei P., Isola L., Bahceci E., Holland K., Rowley S., McGuirk J., et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 2009, 15:804-811.
22. Kurtzberg J., Prockop S., Teira P., Bittencourt H., Lewis V., Chan K.W., et al. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant 2014, 20:229-235.
23. Prasad V.K., Lucas K.G., Kleiner G.I., Talano J.A., Jacobsohn D., Broadwater G., et al. Efficacy and safety of exvivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 2011, 17:534-541.
24. Vaes B., Van't Hof W., Deans R., Pinxteren J. Application of MultiStem((R)) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease. Front Immunol 2012, 3:345.
25. Allison M. Genzyme backs Osiris, despite Prochymal flop. Nat Biotechnol 2009, 27:966-967.
26. Francois M., Copland I.B., Yuan S., Romieu-Mourez R., Waller E.K., Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy 2012, 14:147-152.
27. Galipeau J. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy 2013, 15:2-8.
28. Moll G., Alm J.J., Davies L.C., von Bahr L., Heldring N., Stenbeck-Funke L., et al. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?. Stem Cells 2014, 32:2430-2442.
29. R: A language and environment for statistical computing 2005, Development Core Team, R Foundation for Statistical Computing, Vienna, Austria, ISBN 3-900051-07-0.
30. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
31. Carvalho B.S., Irizarry R.A. Aframework for oligonucleotide microarray preprocessing. Bioinformatics 2010, 26:2363-2367.
32. Wickham H. ggplot2: elegant graphics for data analysis 2009, Springer, New York. 1st ed.
33. Kolde R. Pretty Heatmaps. R package version0.7.7 2013, http://CRAN.R-project.org/package=pheatmap.
34. Ligges U, Mächler M. Scatterplot3d-an r package for visualizing multivariate data: Technical Report, SFB 475: Komplexitätsreduktion in Multivariaten Datenstrukturen, Universität Dortmund;2002.
35. Bai L., Lennon D.P., Eaton V., Maier K., Caplan A.I., Miller S.D., et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57:1192-1203.
36. Bonfield T.L., Koloze M., Lennon D.P., Zuchowski B., Yang S.E., Caplan A.I. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010, 299:L760-770.
37. Thirumala S., Goebel W.S., Woods E.J. Manufacturing and banking of mesenchymal stem cells. Expert Opin Biol Ther 2013, 13:673-691.
38. Ginis I., Grinblat B., Shirvan M.H. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods 2012, 18:453-463.
39. Haack-Sorensen M., Bindslev L., Mortensen S., Friis T., Kastrup J. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. Cytotherapy 2007, 9:328-337.
40. Kotobuki N., Hirose M., Machida H., Katou Y., Muraki K., Takakura Y., et al. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng 2005, 11:663-673.
41. Mamidi M.K., Nathan K.G., Singh G., Thrichelvam S.T., Mohd Yusof N.A., Fakharuzi N.A., et al. Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation. JCell Biochem 2012, 113:3153-3164.
42. Martinello T., Bronzini I., Maccatrozzo L., Mollo A., Sampaolesi M., Mascarello F., et al. Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res Vet Sci 2011, 91:18-24.